Geller Advisors LLC Has $411,000 Stake in Danaher Co. (NYSE:DHR)

Geller Advisors LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 3.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,787 shares of the conglomerate’s stock after selling 72 shares during the period. Geller Advisors LLC’s holdings in Danaher were worth $411,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Gotham Asset Management LLC increased its stake in shares of Danaher by 29.0% in the 4th quarter. Gotham Asset Management LLC now owns 57,043 shares of the conglomerate’s stock valued at $13,094,000 after acquiring an additional 12,828 shares during the last quarter. Focus Partners Wealth grew its holdings in shares of Danaher by 19.8% in the 4th quarter. Focus Partners Wealth now owns 177,596 shares of the conglomerate’s stock valued at $40,818,000 after buying an additional 29,409 shares during the period. Full Sail Capital LLC raised its stake in Danaher by 2.5% during the 4th quarter. Full Sail Capital LLC now owns 2,730 shares of the conglomerate’s stock worth $627,000 after buying an additional 66 shares during the period. Elefante Mark B bought a new stake in shares of Danaher in the fourth quarter worth about $3,428,000. Finally, Ensign Peak Advisors Inc grew its position in shares of Danaher by 1.9% in the 4th quarter. Ensign Peak Advisors Inc now owns 1,306,654 shares of the conglomerate’s stock valued at $299,942,000 after purchasing an additional 24,888 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

DHR opened at $189.42 on Friday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The firm has a market cap of $135.56 billion, a P/E ratio of 35.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The business’s fifty day moving average is $198.39 and its 200-day moving average is $219.46.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. Danaher’s dividend payout ratio is currently 24.85%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on DHR. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a research note on Friday, March 14th. Robert W. Baird decreased their price objective on Danaher from $231.00 to $225.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Citigroup restated a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Danaher from $280.00 to $260.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $264.40.

Insider Transactions at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business’s stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.